UKHSA and PACE make new bacteria available to support research into tackling antimicrobial resistance

• UKHSA and PACE have made WHO-priority threat bacteria available to researchers, expanding access to organisms critical for antimicrobial resistance (AMR) research and drug development
• The bacterial collections enable UK and international scientists to study high-risk pathogens systematically, accelerating evidence generation for new therapeutic strategies
• Increased availability of reference strains supports laboratory capacity for AMR surveillance and resistance mechanism investigation, strengthening the evidence base for clinical interventions

The collections cover bacteria identified as priority threats by the World Health Organization.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.